OSAKA, Japan & CAMBRIDGE, Mass. & NEWARK, Calif.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) and Protagonist Therapeutics (Nasdaq: PTGX) (“Protagonist”) announced the submission of a New Drug ...

Takeda ( TSE:4502/NYSE:TAK) and Protagonist Therapeutics (Nasdaq: PTGX) (“Protagonist”) announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking ...

Treatment costs for diabetes totalled $153.2 billion annually in 2021-2022, with an average annual cost of $5,810 per adult with treated diabetes. That is according to a December statistical brief ...

The World Health Organization (WHO) on Monday issued its first-ever global guidelines on the use of GLP-1 medications for treating obesity as a chronic illness. In a press release, the WHO said this ...

Differentiated thyroid cancer is the most frequently diagnosed thyroid cancer in the U.S. Recently, the American Thyroid Association (ATA) released new practice guidelines for Differentiated thyroid ...

For the first time, sexual medicine experts have created treatment guidelines and recommendations for women who experience low sexual desire or Hypoactive Sexual Desire Disorder (HSDD), a common yet ...

The main component of Besremi, interferon alfa, is a type of medicine that works by affecting the bone marrow, where blood cells are made. It attaches to “docking sites” (receptors) called interferon ...

YouTube on Monday agreed to pay $24.5 million to settle a lawsuit brought by President Trump, and the bulk of the money will go toward the construction of the new White House ballroom. Trump sued the ...

Mr. Trump had sued Alphabet, the parent of YouTube and Google, and other social media companies after the platforms suspended his accounts following the Jan. 6, 2021, riot at the Capitol. By Kate ...

YouTube says it has paid out $100 billion over the past four years to creators, artists and media companies. The company made the announcement at its annual Made on YouTube event Thursday, held in ...

Nearly half of all adults in the U.S. have high blood pressure, a leading contributor to heart attacks, strokes, kidney disease and cognitive decline, according to a new 2025 guideline jointly ...

WASHINGTON, Aug. 28, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (VNDA) today announced the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for VGT-1849B, a selective ...